Medical Innovation

Bi

The Gregorio Marañón University Hospital has successfully performed Europe's first partial heart transplant on a seven-month-old baby. Mariami is recovering well after leaving Intensive Care just two days post-surgery. This breakthrough, endorsed by transplant authorities, combines pioneering techniques and could transform treatments for children with heart defects.

An Ruwaito ta hanyar AI

Scientists at the Hebrew University of Jerusalem have developed a new drug molecule that specifically destroys TERRA, an RNA essential for some cancer cells' survival. Using a technique called RIBOTAC, the drug identifies and breaks down this RNA without harming healthy cells. Tests in cancer cell lines showed reduced growth, suggesting potential for novel therapies.

Wannan shafin yana amfani da cookies

Muna amfani da cookies don nazari don inganta shafin mu. Karanta manufar sirri mu don ƙarin bayani.
Ƙi